Видео ютуба по тегу Trial: Improvemf

An update of IMproveMF: dose-escalation of imetelstat + ruxolitinib in patients with myelofibrosis
An update of IMproveMF: dose-escalation of imetelstat + ruxolitinib in patients with myelofibrosis
The IMproveMF study: combining imetelstat with ruxolitinib for the treatment of myelofibrosis
The IMproveMF study: combining imetelstat with ruxolitinib for the treatment of myelofibrosis
IMPROVE-MF: imetelstat and ruxolitinib in patients with myelofibrosis
IMPROVE-MF: imetelstat and ruxolitinib in patients with myelofibrosis
Introducing the Phase III EPCORE FL-1 trial: epcoritamab plus R2 versus R2 for R/R FL
Introducing the Phase III EPCORE FL-1 trial: epcoritamab plus R2 versus R2 for R/R FL
Phase II trial of early-line anti-EGFR therapy to facilitate retreatment for patients with mCRC
Phase II trial of early-line anti-EGFR therapy to facilitate retreatment for patients with mCRC
The myeloMATCH clinical trials: Improving personalized treatment in AML
The myeloMATCH clinical trials: Improving personalized treatment in AML
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF
COMFORT-II clinical trial: the 5 yr results
COMFORT-II clinical trial: the 5 yr results
Safety of treating myelofibrosis with ruxolitinib – results from JUMP trial
Safety of treating myelofibrosis with ruxolitinib – results from JUMP trial
My approach to MF management
My approach to MF management
Clinical trial round-up: Treating anemia in patients with myelofibrosis
Clinical trial round-up: Treating anemia in patients with myelofibrosis
Updated results from the RESTORE trial: elritercept in patients with MF receiving ruxolitinib
Updated results from the RESTORE trial: elritercept in patients with MF receiving ruxolitinib
Measuring disease modification in MPN clinical trials
Measuring disease modification in MPN clinical trials
Understanding the Clinical Trial Process
Understanding the Clinical Trial Process
HFpEF в клинической практике: диагностика, подводные камни и лечение на основе рекомендаций
HFpEF в клинической практике: диагностика, подводные камни и лечение на основе рекомендаций
Tranexamic Acid Is Not for Everyone: What the Mega-Trials Revealed
Tranexamic Acid Is Not for Everyone: What the Mega-Trials Revealed
What Are the Phases of Clinical Trials?
What Are the Phases of Clinical Trials?
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF
Phase 3 Trial of Momelotinib Versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis
Phase 3 Trial of Momelotinib Versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis
Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL